Statins and the risk of Parkinson disease: an update on the controversy

Author： Becker Claudia Meier Christoph R

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.8, Iss.3, 2009-05, pp. : 261-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Statins and the Risk of Parkinson's Disease: A Retrospective Case-Control Study in the UK

By Becker Claudia

Drug Safety, Vol. 31, Iss. 5, 2008-01 ,pp. : 399-407

Adis International

Access to resources Recommend Favorite

Gene therapy for Parkinson’s disease: review and update

By Kang U.J. Frim D.M.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1551-1564

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic Optimisation in the Treatment of Parkinson's Disease: An Update

By Nyholm Dag

Clinical Pharmacokinetics, Vol. 45, Iss. 2, 2006-01 ,pp. : 109-136

Adis International

Access to resources Recommend Favorite

Pathological Gambling in Parkinson's Disease: An Update on Medical Management

By Pirritano Domenico Plastino Massimiliano Fava Antonietta Cristiano Dario Gallelli Luca Colica Carmela Bosco Domenico

Current Psychopharmacology, Vol. 1, Iss. 4, 2012-11 ,pp. : 365-374

Bentham Science Publishers

Access to resources Recommend Favorite

All for Statins and Statins for All; An Update

Current Pharmaceutical Design, Vol. 22, Iss. 1, 2016-01 ,pp. : 18-27

Bentham Science Publishers

Access to resources Recommend Favorite